ADC Therapeutics vs Kura Oncology
ADCT and KURA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ADCT and KURA compare
Kura Oncology is the larger company, worth 4.0 times as much as ADC Therapeutics ($631M against $160M).
ADC Therapeutics keeps more of each dollar of sales as profit, with a net margin of −95.7% compared with −369% at Kura Oncology.
ADC Therapeutics scores higher on the StockData Score (4 against 1 for Kura Oncology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ADCT | KURA |
|---|---|---|
| Size and price | ||
| Market cap | $160M | $631M |
| Share price | $1.25 | $7.09 |
| Change, 1 year | −69.1% | −33.6% |
| Change, 5 years | −94.4% | −49.4% |
| Beta (5Y) | 2.95 | 2.37 |
| Employees | 188 | 260 |
| StockData Score | ||
| Total score | 4 (better) | 1 |
| Valuation score | 1 (better) | 0 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 (better) | 0 |
| Health score | 1 | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.9× (better) | 8.0× |
| P/B | – | 35.1× |
| FCF yield | −63.0% | −14.1% (better) |
| Growth | ||
| Revenue growth (TTM) | 12.8% | – |
| Profitability | ||
| Operating margin | −97.7% (better) | −394% |
| Net margin | −95.7% (better) | −369% |
| FCF margin | −118% | −112% (better) |
| Return on equity | – | −225% |
| Financial health | ||
| Debt / equity | – | 0.55 |
| Interest coverage | −1.6× (better) | −227.1× |
| Current ratio | 3.05 | 3.60 (better) |
| Altman Z-score | −9.16 | −3.60 (better) |
| Piotroski F-score | 6 (better) | 1 |
| Dividends and buybacks | ||
| Buyback yield | −26.7% | – |
| Shareholder yield | −26.7% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 72.9% | 98.0% |
| Held by insiders | 42.8% | 2.5% |
| Insider net buying, 12 months | −$19.6M | −$993K (better) |
| Short interest, % of float | 8.8% | 14.6% |
Go deeper
- ADCT stock overview
- ADCT income statement
- ADCT valuation and score
- KURA stock overview
- KURA income statement
- KURA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.